Pharmaceutical compositions are provided comprising particulate valdecoxib i n an amount of about 1 mg to about 100 mg and one or more pharmaceutically acceptable excipients. The compositions are useful in treatment or prophylax is of cyclooxygenase-2 mediated conditions and disorders.

Pharmaceutical compositions are provided comprising particulate valdecoxib in an amount of about 1 mg to about 100 mg and one or more pharmaceutically acceptable excipients. The compositions are useful in treatment or prophylaxis of cyclooxygenase-2 mediated conditions and disorders.

Pharmaceutical compositions are provided comprising particulate valdecoxib in an amount of about 1 mg to about 100 mg and one or more pharmaceutically acceptable excipients. The compositions are useful in treatment or prophylaxis of cyclooxygenase-2 mediated conditions and disorders.

SE REFIERE A UNA COMPOSICION QUE COMPRENDE: a)UN AGONISTA DE RECEPTORES 5HT1 TAL COMO ELETRIPTAN RIZATRIPTAN ZOLMITRIPTAN SUMATRIPTAN NARATRIPTAN; UTILIZANDOSE 005 mg/DIA A 100 mg/DIA; b)UN INHIBIDOR DE CICLOOXIGENASA UTILIZANDOSE DE 10 mg/DIA A 300 mg/DIA; DE PREFERENCIA b1)UN COMPUESTO PIRAZOL DIARIL SUSTITUIDO DE FORMULA I; DONDE: R1 ES SULFAMILO R2 ES HALOALQUILO; R3 ES HIDRURO ALQUILO; R4 ES ARILO CICLOALQUILO CICLOALQUENILO OPCIONALMENTE SUSTITUIDO CON HALO ALQUILTIO ALQUILSULFINILO ENTRE ...

SE REFIERE A UNA COMPOSICION QUE COMPRENDE a)DE 0.05 A 100 mg/DIA DE UN AGONISTA DE RECEPTORES 5HT1 COMO ELETRIPTAN RIZATRIPTAN ZOLMITRIPTAN SUMATRIPTAN NARATRIPTAN b)UN COMPUESTO IMIDAZOL SUSTITUIDO CON BENCENO DE FORMULA I DONDE: R1 ES SULFAMILO; R2 ES HALOALQUILO; R3 ES ALQUILO ENTRE OTROS; R4 ES ARILO CICLOALQUILO CICLOALQUENILO OPCIONALMENTE SUSTITUIDO CON HALO ALQUILTIO ALQUILSULFINILO ENTRE OTROS; o UN COMPUESTO OXAZOL SUSTITUIDO DE FORMULA II DONDE: R1 ES ALQUILO CARBOXIALQUILO ALCOXICAR...